UCHL1 and cardiac hypertrophy: The cardiac dysfunction of mice with cardiac hypertrophy induced by TAC was dramatically relieved after treatment with LDN-57444, an inhibitor of UCHL1, indicating that UCHL1 may be employed as a potential drug target for the therapy of cardiac hypertrophy in the future.